Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia

Hypertension in Pregnancy

Volumn 31, Issue 1, 2012, Pages 70-78

  Uddin, Mohammad Nasir ^a   Agunanne, Enoch E ^a   Horvat, Darijana ^a   Puschett, Jules B ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Animal model; Marinobufagenin; Oxidative stress; Preeclampsia; Resibufogenin

Indexed keywords

8 ISOPROSTANE; ADENOSINE A1 RECEPTOR; BETA ACTIN; BUFOGENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE EXPRESSION; HEMATOCRIT; NONHUMAN; OXIDATIVE STRESS; PREECLAMPSIA; RAT; URINARY EXCRETION;

ANIMALS; BUFANOLIDES; DISEASE MODELS, ANIMAL; FEMALE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84455191953     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2010.525275     Document Type: Article

References (31)

1. Pridjian G, Puschett JB. Preeclampsia, part I: Clinical and pathophysiological considerations. Obstet Gynecol Surv 2002; 57:598-618. (Pubitemid 34977665)
2. Pridjian G, Puschett JB. Preeclampsia, part II: Experimental and genetic considerations. Obstet Gynecol Surv 2002; 57:619-640. (Pubitemid 34977666)
3. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996; 88:161-167. (Pubitemid 26250284)
4. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451. (Pubitemid 23161452)
5. Ianosi-Irimie M, Vu HV, Whitbred JM, et al. A rat model of preeclampsia. Clin Exp Hypertens 2005; 27:605-617. (Pubitemid 41722067)
6. Vu HV, Ianosi-Irimie M, Pridjian CA, et al. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005; 25:520-528. (Pubitemid 41433898)
7. Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem 2008; 283(26):17946-17953.
8. Uddin MN, Horvat D, Glaser SS, et al. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 2008; 29:266-273.
9. LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB. Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 2006; 27:984-988. (Pubitemid 44204032)
10. Uddin MN, McLean LB, Hunter FA, et al. Vascular leak in a rat model of preeclampsia. Am J Nephrol 2009; 30:26-33.
11. Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Obstet Gynecol 1985; 151:958-966. (Pubitemid 15237734)
12. Gallery EDM, Hunyor SN, Györy AZ. Plasma volume contraction: A significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 1979; 48:593-602. (Pubitemid 10210779)
13. Vu H, Ianosi-Irimie M, Danchuk S, et al. Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med 2006; 231:215-220. (Pubitemid 43213459)
14. Danchuk S, Sukhanov S, Horvat D, Uddin MN, Puschett JB. Effects of resibufogenin in experimental hypertension. Am J Nephrol 2008; 28:8-13. (Pubitemid 350126488)
15. Horvat D, Severson J, Uddin MN, Mitchell B, Puschett JB. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy 2009; 25:1-9.
16. Uddin MN, Agunanne E, Horvat D, Puschett JB. Alterations in the renin-angiotensin system in a rat model of preeclampsia. Am J Nephrol 2010; 31:171-177. DOI: 10.1159/000267099.
17. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-1148. (Pubitemid 24176909)
18. Romero JC, Reckelhoff JF. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999; 34:943-949. (Pubitemid 29501328)
19. Nickenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis, part I: Oxidative stress and atherogenesis. Circulation 2002; 105:393-396. (Pubitemid 34106191)
20. Wassmann S, Stumpf M, Strehlow K, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 2004; 94:534-541. (Pubitemid 38326289)
21. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004; 18:1791-1800. (Pubitemid 39602265)
22. Staff AC, Halvorsen B, Ranheim T, Henriksen T. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia. Am J Obstet Gynecol 1999; 181:1211-1215.
23. Scott DE. Anemia in pregnancy. Obstet Gynecol Annu 1972; 1:219-244.
24. Bagrov AY, Fedorova OV. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J Hypertens 1998; 16:1953-1958. (Pubitemid 29002373)
25. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens 2005; 23:1515-1523. (Pubitemid 41104823)
26. Puschett JB. The role of excessive volume expansion in the pathogenesis of preeclampsia. Med Hypotheses 2006; 67:1125-1132. (Pubitemid 44302258)
27. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostane) in smokers. N Engl J Med 1995; 332:1198-1203.
28. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 1999; 33:424-428. (Pubitemid 29065696)
29. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222-235.
30. Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995; 80:1888-1893.
31. Agunanne EE, Uddin MN, Horvat D, Puschett JB. Contribution of angiogenic factors in a rat model of preeclampsia. Am J Nephrol 2010; 32:332-339.